Loading
Loading…
Loading…
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
4 Aug 2026, 12:00 pm
bid 03
9626842
GEM/2026/B/7804729
Two Packet Bid
Atropine Sulphate 0 point 6 mg 1 ml Inj,Suspension Syp Fexofenadine 30 mg 5ml comma 60 ml bottle,De
Bathinda, Punjab
Total value wise evaluation
BOQ
7 documents required · 7 mandatory
2 yrs
₹1 L
₹1 L
40%
Exempted
Yes
25 Jul 2026
25 Jul 2026
4 Aug 2026
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|
| 1 | Atropine Sulphate 0 point 6 mg 1 ml Inj | 120 | Amp Vial | BHATINDA | 21 |
| 2 | Suspension Syp Fexofenadine 30 mg 5ml comma 60 ml bottle | 60 | Bott | BHATINDA | 21 |
| 3 | Dexamethasone Sodium Phosphate 4point4 mg Equivalent to Dexamethasone Phosphate 4 mg ml 2 ml Inj | 60 | Amp Vial | BHATINDA | 21 |
| 4 | Pheniramine Maleate Inj 22 pint75 mg ml amp of 2 ml | 300 | Amp Vial | BHATINDA | 21 |
| 5 | Pheniramine Maleate 25 mg Tab | 3,000 | No | BHATINDA | 21 |
| 6 | Albendazole Syp each 5 ml containing 200 mg bott of 10 ml | 300 | Bott | BHATINDA | 21 |
| 7 | Silver Sulphadiazine 1 percent Ointment 20 gm tube | 150 | Tube | BHATINDA | 21 |
| 8 | Medroxy progesterone 5 mg Tab | 150 | No | BHATINDA | 21 |
| 9 | Isosorbide Dinitrate 10 mg Tab | 600 | No | BHATINDA | 21 |
| 10 | Benzocaine 20 percent comma Pectin based comma oral ointment Tube of 5 gm | 150 | Tube | BHATINDA | 21 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_9626842.pdf
GEM_BID • 0.30 MB
boq_3_2026-07-18-11-37-31_c066671a5d18d95c08bf87f4c2cc9737.pdf
BOQ • 1.62 MB
boq_item_sample_file-1_2026-07-18-11-37-31_077f9b7d6a59aca33c607584d0f68546.csv
BOQ • 0.01 MB
gtc.pdf
GEM_OTHER • 0.71 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at [email protected].